We have recently suggested that NT-proBNP might have a relevant role in early identification of type 2 diabetic patients at increased CV risk as in the Casale Monferrato cohort a slight increase in NT-proBNP levels was a strong independent predictor of CV mortality even in patients without pre-existing CVD [7]. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.